These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 15963279

  • 21. Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study.
    Farrell DJ, File TM, Jenkins SG.
    J Clin Microbiol; 2007 Feb; 45(2):290-3. PubMed ID: 17093012
    [Abstract] [Full Text] [Related]

  • 22. Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
    Xu X, Cai L, Xiao M, Kong F, Oftadeh S, Zhou F, Gilbert GL.
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1152-9. PubMed ID: 20065057
    [Abstract] [Full Text] [Related]

  • 23. Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era.
    Liu Z, Nachamkin I, Edelstein PH, Lautenbach E, Metlay JP.
    Antimicrob Agents Chemother; 2012 Feb; 56(2):743-50. PubMed ID: 22123697
    [Abstract] [Full Text] [Related]

  • 24. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
    Van Eldere J, Meekers E, Lagrou K, Massonet C, Canu A, Devenyns I, Verhaegen J, Syrogiannopoulos G, Leclercq R.
    Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
    [Abstract] [Full Text] [Related]

  • 25. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A, Koncan R, Vitali LA, Cornaglia G.
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [Abstract] [Full Text] [Related]

  • 26. Lack of correlation between reduced outpatient consumption of macrolides and macrolide resistance of invasive Streptococcus pneumoniae isolates in Slovenia during 1997-2017.
    Kastrin T, Paragi M, Erčulj V, Žohar Čretnik T, Slovenian Meningitidis Study Group, Bajec T, Čižman M.
    J Glob Antimicrob Resist; 2019 Mar; 16():242-248. PubMed ID: 30391398
    [Abstract] [Full Text] [Related]

  • 27. Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France.
    Marchandin H, Jean-Pierre H, Jumas-Bilak E, Isson L, Drouillard B, Darbas H, Carrière C.
    Pathol Biol (Paris); 2001 Sep; 49(7):522-7. PubMed ID: 11642013
    [Abstract] [Full Text] [Related]

  • 28. Antibacterial susceptibility among Streptococcus pneumoniae isolated from paediatric and adult patients as part of the PROTEKT US study in 2001-2002.
    Brown SD, Farrell DJ.
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i23-9. PubMed ID: 15265833
    [Abstract] [Full Text] [Related]

  • 29. Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany.
    van der Linden M, Al-Lahham A, Haupts S, Reinert RR.
    Antimicrob Agents Chemother; 2007 May; 51(5):1830-4. PubMed ID: 17325214
    [Abstract] [Full Text] [Related]

  • 30. Dominance of multidrug resistant CC271 clones in macrolide-resistant streptococcus pneumoniae in Arizona.
    Bowers JR, Driebe EM, Nibecker JL, Wojack BR, Sarovich DS, Wong AH, Brzoska PM, Hubert N, Knadler A, Watson LM, Wagner DM, Furtado MR, Saubolle M, Engelthaler DM, Keim PS.
    BMC Microbiol; 2012 Jan 18; 12():12. PubMed ID: 22251616
    [Abstract] [Full Text] [Related]

  • 31. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
    Song JH, Chang HH, Suh JY, Ko KS, Jung SI, Oh WS, Peck KR, Lee NY, Yang Y, Chongthaleong A, Aswapokee N, Chiu CH, Lalitha MK, Perera J, Yee TT, Kumararasinghe G, Jamal F, Kamarulazaman A, Parasakthi N, Van PH, So T, Ng TK, ANSORP Study Group.
    J Antimicrob Chemother; 2004 Mar 18; 53(3):457-63. PubMed ID: 14963068
    [Abstract] [Full Text] [Related]

  • 32. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C, van der Linden M, Reinert RR.
    Int J Antimicrob Agents; 2011 May 18; 37(5):425-31. PubMed ID: 21419605
    [Abstract] [Full Text] [Related]

  • 33. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.
    Wolter N, von Gottberg A, du Plessis M, de Gouveia L, Klugman KP, Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa.
    Int J Antimicrob Agents; 2008 Jul 18; 32(1):62-7. PubMed ID: 18339522
    [Abstract] [Full Text] [Related]

  • 34. Macrolide-resistant Streptococcus pneumoniae clinical isolates that occur in Hokkaido prefecture, Japan.
    Yokota S, Sato K, Yoshida S, Hayashi T, Matsuda K, Kuwahara O, Habadera S, Kobayashi K, Ueno R, Akizawa H, Fujii N.
    J Infect Chemother; 2004 Oct 18; 10(5):284-7. PubMed ID: 16163463
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
    Felmingham D, Reinert RR, Hirakata Y, Rodloff A.
    J Antimicrob Chemother; 2002 Sep 18; 50 Suppl S1():25-37. PubMed ID: 12239226
    [Abstract] [Full Text] [Related]

  • 37. Prevalence of erm(A) and mef(B) erythromycin resistance determinants in isolates of Streptococcus pneumoniae from New Zealand.
    Bean DC, Klena JD.
    J Antimicrob Chemother; 2002 Oct 18; 50(4):597-9. PubMed ID: 12356808
    [Abstract] [Full Text] [Related]

  • 38. Dissemination of macrolide-resistant Streptococcus pneumoniae isolates containing both erm(B) and mef(A) in South Korea.
    Waites KB, Jones KE, Kim KH, Moser SA, Johnson CN, Hollingshead SK, Kang ES, Hong KS, Benjamin WH.
    J Clin Microbiol; 2003 Dec 18; 41(12):5787-91. PubMed ID: 14662984
    [Abstract] [Full Text] [Related]

  • 39. Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city.
    Toltzis P, Dul M, O'Riordan MA, Jacobs MR, Blumer J.
    Pediatr Infect Dis J; 2006 Jan 18; 25(1):19-24. PubMed ID: 16395097
    [Abstract] [Full Text] [Related]

  • 40. Molecular resistance mechanisms of macrolide-resistant invasive Streptococcus pneumoniae isolates from Alaska, 1986 to 2010.
    Rudolph K, Bulkow L, Bruce M, Zulz T, Reasonover A, Harker-Jones M, Hurlburt D, Hennessy T.
    Antimicrob Agents Chemother; 2013 Nov 18; 57(11):5415-22. PubMed ID: 23959308
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.